Wanbang Pharmaceuticals and Kangwei Xun Biotechnology have reached a strategic cooperation agreement.

Recently, Anhui Wanbang Pharmaceutical Technology Co., Ltd. officially reached a deep strategic cooperation with Suzhou Kangweixun Biotechnology Co., Ltd. The two parties will rely on their respective core strengths to achieve deep integration of preclinical, clinical biomarker analysis, and full-process clinical research services, empowering the efficient research and development of innovative drugs, improved new drugs, and generic drugs in all aspects.